3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
2
Neoplasms
2
Malnutrition
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Thrombosis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
Protein Metabolism
1
Polycystic Ovary Syndrome
1
Pain
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Meningioma
1
Hemorrhage
1
Glioblastoma
1
Erectile Dysfunction
1
Disease
1
Diabetes Insipidus
1
Brain Neoplasms
1
Interventions
Surveys and Questionnaires
15
Acupuncture Therapy
15
Fentanyl
14
Morphine
13
Acetaminophen
13
Analgesia
12
Lidocaine
11
Ketamine
11
Bupivacaine
11
Methadone
10
Therapeutics
9
Ropivacaine
9
Psychiatric Rehabilitation
9
Oxycodone
9
Hydromorphone
7
Saline Solution
6
Radiotherapy
6
Music Therapy
6
Early Intervention, Educational
6
Zoledronic Acid
5
Yoga
5
Water
5
Methods
5
Control Groups
5
Transcutaneous Electric Nerve Stimulation
4
Therapeutic Touch
4
Physical Therapy Modalities
4
Massage
4
Ketorolac
4
Exercise
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pain
×
Arginine
×
Clear all
NCT05293041
2025-03-06
ARG-01
Sahlgrenska University Hospital
Phase 4
Completed
248 enrolled